TRADES
Latest Trades
2712
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKK 5 Jan 2022 Buy CRSP CRISPR THERAPEUTICS AG 29,500 0.0131
ARKK 5 Jan 2022 Buy BEAM BEAM THERAPEUTICS INC 14,100 0.0064
ARKK 4 Jan 2022 Sell TWTR TWITTER INC 1,918,777 0.4734
ARKK 4 Jan 2022 Buy TWOU 2U INC 43,000 0.0052
ARKK 4 Jan 2022 Sell TSLA TESLA INC 27,574 0.1993
ARKK 4 Jan 2022 Buy SSYS STRATASYS LTD 53,000 0.0077
ARKK 4 Jan 2022 Buy SQ SQUARE INC 304,356 0.2811
ARKK 4 Jan 2022 Buy RBLX ROBLOX CORP 332,950 0.1885
ARKK 4 Jan 2022 Buy NVTA INVITAE CORP 32,000 0.0028
ARKK 4 Jan 2022 Buy NTLA INTELLIA THERAPEUTICS INC 72,829 0.0498
ARKK 4 Jan 2022 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 329,582 0.0371
ARKK 4 Jan 2022 Buy DKNG DRAFTKINGS INC 1,185,460 0.1936
ARKK 4 Jan 2022 Buy BLI BERKELEY LIGHTS INC 4,800 0.0005
ARKK 3 Jan 2022 Sell U UNITY SOFTWARE INC 5,949 0.0053
ARKK 3 Jan 2022 Buy TWOU 2U INC 8,518 0.0011
ARKK 3 Jan 2022 Buy TDOC TELADOC HEALTH INC 37,481 0.0218
ARKK 3 Jan 2022 Buy SSYS STRATASYS LTD 6,363 0.0010
ARKK 3 Jan 2022 Buy NVTA INVITAE CORP 89,426 0.0084
ARKK 3 Jan 2022 Sell IRDM IRIDIUM COMMUNICATIONS INC 185,119 0.0479
ARKK 3 Jan 2022 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 916,296 0.1087
ARKK 3 Jan 2022 Buy BLI BERKELEY LIGHTS INC 1,655 0.0002
ARKK 3 Jan 2022 Buy BEAM BEAM THERAPEUTICS INC 81,106 0.0395
ARKK 31 Dec 2021 Sell U UNITY SOFTWARE INC 58,442 0.0516
ARKK 31 Dec 2021 Buy TDOC TELADOC HEALTH INC 28,000 0.0158
ARKK 31 Dec 2021 Buy SSYS STRATASYS LTD 50,004 0.0075
ARKK 31 Dec 2021 Sell IRDM IRIDIUM COMMUNICATIONS INC 18,967 0.0049
ARKK 31 Dec 2021 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 181,724 0.0213
ARKK 31 Dec 2021 Buy HOOD ROBINHOOD MARKETS INC 537,956 0.0591
ARKK 31 Dec 2021 Buy DKNG DRAFTKINGS INC 38,846 0.0067
ARKK 31 Dec 2021 Buy BLI BERKELEY LIGHTS INC 24,330 0.0027
ARKK 30 Dec 2021 Buy ZM ZOOM VIDEO COMMUNICATIONS INC 132,682 0.1578
ARKK 30 Dec 2021 Buy TWOU 2U INC 9,093 0.0012
ARKK 30 Dec 2021 Sell TSLA TESLA INC 23,942 0.1622
ARKK 30 Dec 2021 Buy TDOC TELADOC HEALTH INC 2,056 0.0012
ARKK 30 Dec 2021 Buy SSYS STRATASYS LTD 25 0.0000
ARKK 30 Dec 2021 Buy SQ BLOCK INC 194,675 0.2031
ARKK 30 Dec 2021 Sell SPOT SPOTIFY TECHNOLOGY SA 108,867 0.1625
ARKK 30 Dec 2021 Sell SHOP SHOPIFY INC 17,941 0.1588
ARKK 30 Dec 2021 Buy NVTA INVITAE CORP 4,329 0.0004
ARKK 30 Dec 2021 Sell IRDM IRIDIUM COMMUNICATIONS INC 380,778 0.1007
ARKK 30 Dec 2021 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 202,646 0.0248
ARKK 30 Dec 2021 Buy HOOD ROBINHOOD MARKETS INC 793,511 0.0905
ARKK 30 Dec 2021 Buy DKNG DRAFTKINGS INC 543,221 0.0961
ARKK 30 Dec 2021 Buy CRSP CRISPR THERAPEUTICS AG 31,800 0.0157
ARKK 29 Dec 2021 Buy VCYT VERACYTE INC 38,715 0.0091
ARKK 29 Dec 2021 Buy TWOU 2U INC 107,448 0.0130
ARKK 29 Dec 2021 Sell TSLA TESLA INC 22,816 0.1495
ARKK 29 Dec 2021 Buy TDOC TELADOC HEALTH INC 97,300 0.0531
ARKK 29 Dec 2021 Buy SSYS STRATASYS LTD 249,771 0.0358
ARKK 29 Dec 2021 Buy NVTA INVITAE CORP 51,355 0.0045
ARKK 29 Dec 2021 Buy CRSP CRISPR THERAPEUTICS AG 45,500 0.0211
ARKK 28 Dec 2021 Buy VCYT VERACYTE INC 54,872 0.0129
ARKK 28 Dec 2021 Buy TWOU 2U INC 53,758 0.0064
ARKK 28 Dec 2021 Sell TSLA TESLA INC 14,740 0.0950
ARKK 28 Dec 2021 Buy TDOC TELADOC HEALTH INC 50,318 0.0272
ARKK 28 Dec 2021 Buy SSYS STRATASYS LTD 12,454 0.0018
ARKK 28 Dec 2021 Buy SGFY SIGNIFY HEALTH INC 20,000 0.0016
ARKK 28 Dec 2021 Buy DNA GINKGO BIOWORKS HOLDINGS INC 128,857 0.0074
ARKK 28 Dec 2021 Buy CRSP CRISPR THERAPEUTICS AG 6,900 0.0032
ARKK 28 Dec 2021 Buy BLI BERKELEY LIGHTS INC 44,000 0.0048
ARKK 27 Dec 2021 Sell ZM ZOOM VIDEO COMMUNICATIONS INC 28,481 0.0313
ARKK 27 Dec 2021 Sell VCYT VERACYTE INC 11,900 0.0028
ARKK 27 Dec 2021 Sell U UNITY SOFTWARE INC 35,173 0.0300
ARKK 27 Dec 2021 Sell TXG 10X GENOMICS INC 12,511 0.0106
ARKK 27 Dec 2021 Sell TWTR TWITTER INC 67,816 0.0175
ARKK 27 Dec 2021 Sell TWST TWIST BIOSCIENCE CORP 11,046 0.0053
ARKK 27 Dec 2021 Sell TWOU 2U INC 35,318 0.0043
ARKK 27 Dec 2021 Sell TWLO TWILIO INC 16,295 0.0252
ARKK 27 Dec 2021 Sell TSP TUSIMPLE HOLDINGS INC 40,900 0.0089
ARKK 27 Dec 2021 Sell TSLA TESLA INC 23,495 0.1496
ARKK 27 Dec 2021 Sell TRMB TRIMBLE INC 13,421 0.0068
ARKK 27 Dec 2021 Sell TDOC TELADOC HEALTH INC 67,719 0.0366
ARKK 27 Dec 2021 Sell SSYS STRATASYS LTD 26,410 0.0036
ARKK 27 Dec 2021 Sell SQ SQUARE INC 21,503 0.0211
ARKK 27 Dec 2021 Sell SPOT SPOTIFY TECHNOLOGY SA 19,345 0.0263
ARKK 27 Dec 2021 Sell SKLZ SKILLZ INC 67,105 0.0033
ARKK 27 Dec 2021 Sell SHOP SHOPIFY INC 2,784 0.0232
ARKK 27 Dec 2021 Sell SGFY SIGNIFY HEALTH INC 20,321 0.0017
ARKK 27 Dec 2021 Sell ROKU ROKU INC 28,696 0.0387
ARKK 27 Dec 2021 Sell RBLX ROBLOX CORP 4,470 0.0027
ARKK 27 Dec 2021 Sell PLTR PALANTIR TECHNOLOGIES INC 150,219 0.0165
ARKK 27 Dec 2021 Sell PD PAGERDUTY INC 17,221 0.0036
ARKK 27 Dec 2021 Sell PATH UIPATH INC 90,357 0.0233
ARKK 27 Dec 2021 Sell PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC 60,066 0.0073
ARKK 27 Dec 2021 Sell NVTA INVITAE CORP 61,600 0.0058
ARKK 27 Dec 2021 Sell NTLA INTELLIA THERAPEUTICS INC 32,429 0.0235
ARKK 27 Dec 2021 Sell MTLS MATERIALISE NV 10,529 0.0015
ARKK 27 Dec 2021 Sell IRDM IRIDIUM COMMUNICATIONS INC 41,181 0.0100
ARKK 27 Dec 2021 Sell IOVA IOVANCE BIOTHERAPEUTICS INC 28,105 0.0033
ARKK 27 Dec 2021 Sell HOOD ROBINHOOD MARKETS INC 81,304 0.0088
ARKK 27 Dec 2021 Sell FATE FATE THERAPEUTICS INC 13,150 0.0048
ARKK 27 Dec 2021 Sell EXAS EXACT SCIENCES CORP 25,880 0.0116
ARKK 27 Dec 2021 Sell EDIT EDITAS MEDICINE INC 13,200 0.0023
ARKK 27 Dec 2021 Sell DOCU DOCUSIGN INC 10,397 0.0095
ARKK 27 Dec 2021 Sell DNA GINKGO BIOWORKS HOLDINGS INC 75,310 0.0045
ARKK 27 Dec 2021 Sell DKNG DRAFTKINGS INC 53,200 0.0090
ARKK 27 Dec 2021 Sell DDD 3D SYSTEMS CORP 7,565 0.0010
ARKK 27 Dec 2021 Sell CRSP CRISPR THERAPEUTICS AG 15,900 0.0075
ARKK 27 Dec 2021 Sell COIN COINBASE GLOBAL INC 21,049 0.0333
ARKK 27 Dec 2021 Sell CGEN COMPUGEN LTD 12,900 0.0003
Latest Blogs
ARK by Cathie Wood is still suffering a year after its apex.

Cathie Wood's flagship exchange-traded fund hit an all-time high in February of this year. Her preferred disruptive-tech chasing strategy may still be in for a lot of suffering after a year and a 53 percent fall.

After a dramatic decline last month, the ARK Innovation ETF (ticker: ARKK) has steadied off - it's practically flat in February – but the headwinds surrounding its speculative growth picks are just becoming more vital. Many businesses that thrived during the pandemic are being hammered by the economic reopening, not only because yields are rising as investors prepare for the US Federal Reserve to raise interest rates, which is terrible news for unprofitable businesses, but also because the economic reopening is hammering many of the businesses that thrived during the pandemic.

Roku, Teladoc, and Zoom, all winners in the work-from-home era, have had their stock prices plummet by as much as 74% in the past year.

Short bets against ARK, according to IHS Markit data, hit a fresh high of 11.4 percent of outstanding shares this week. The Tuttle Capital Short Innovation ETF (SARK), which beats the ARK, now has assets worth more than $US300 million ($416 million).

"Those equities are supported by speculation, and speculation pays less well when the Fed raises rates," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Co. "Much of what's happening in the market reminds me of what happened in the late 1990s when market segments were bid up to levels based on future assumptions."

Because its price chart resembles that of the Nasdaq index of technology businesses from more than two decades ago, analogies to that period and the dot-com implosion that followed are becoming more common in discussions of ARK.

"Today marks the 253rd trading day from ARK's all-time high," Jessica Rabe, co-founder of DataTrek Research, wrote in a Tuesday note, "while the Nasdaq was down 60% from its dot-com bubble top on the same day in 2001."

"If 2000/2001 analog holds, we should see ARK continuing to fall over the following three weeks. The Nasdaq dropped 18.7% in the next 16 trading days "recent."

Net flows are positive.

The better news for investors and Ms. Wood is that there may be some immediate respite. The Nasdaq rose 41% in six weeks in 2001 before falling.

The ARK Investment Management did not respond to a request for comment.

Most of ARK's $US15 billion asset loss has been attributed to bad performance, a plus for the company. Since the fund achieved an intraday high of $US159.70 a year ago this week, investors have withdrawn only around $US465 million, and ARK's net flows this year are positive despite a more than 20% drop.

This exceptional loyalty prevents a worsening situation and allows Wood's approach to recovering. The star fund manager has consistently emphasized that her funds have a five-year investment horizon and that she believes in many good options.

Mr. Schutte, on the other hand, says the drop is understandable because several of the company's biggest bets, such as Teladoc and Zoom, are becoming less significant as COVID-19 approaches.

"During the pandemic, there were a lot of questions about what would happen to society and how we'd go about our lives," he added.

"You drew in new investors who wanted to know "what are the upcoming themes I should invest in?" I believe you got a washout of it as well."

On Friday, Cathie Wood sold $148.9 million worth of Palantir stock, halving her exposure.

Ark Investment Management, run by Cathie Wood, sold more Palantir Technologies Inc PLTR -6.39 percent shares on Friday, cutting its stake in the Peter Thiel-backed company.

According to Friday's closing price, the famous investment management firm sold 13.5 million shares of the big data company, valued at $148.9 million.

Palantir's stock fell 6.4 percent to $11.02 per share on Friday. The stock has lost 16% of its value in the last week.

Before Friday's trade, Ark Invest held 25.53 million shares in Palantir, suggesting that the famous stock picker had trimmed over 52 percent of its total keeping a day later.

After the business disclosed lower-than-expected fourth-quarter earnings before the market opened on Thursday, Ark Invest, located in St. Petersburg, California, dumped shares in Palantir for the second time.

The software firm, well-known for its work with government organizations, posted earnings of 2 cents per share, falling short of the analyst consensus of 4 cents. The company recorded quarterly revenues of $432.87 million, higher than the $417.69 million predicted by analysts.

Palantir's stock had been sold for 4.77 million shares by the investment firm the day before.

All six of Ark Invest's active exchange-traded funds own Palantir stock, including the flagship Ark Innovation ETF ARKK -4.88 percent.

Before the recent sell-off, Ark Invest had been stockpiling Palantir shares for months.

Cathie Wood appeared on television to defend her ARK funds' dismal performance. It didn't go quite as planned.

The Ark Innovation ETF (ARKK), Cathie Wood's flagship fund, is down 30% year to date and more volatile than almost any other fund on the market. On CNBC's Halftime Report, Wood jumped at the chance to defend the fund and its deflated price, which is currently $68.80, down from $155 a year ago.

"We've seen a significant decline," Wood said, adding, "We feel innovation is at bargain basement zone." Even though her ETF was underperforming, she emphasized that her companies were still "very inexpensive" and that the current fund loss was temporary. When the call's 40 free minutes were finished, Zoom gave her an extra 10 minutes to complete the interview.

Having Zoom check to see whether she was "running out of time?" Wood, who has been aggressively buying up shares in Zoom and other IT firms that have fallen from their pandemic highs, was unhappy. Zoom, like Wood's other significant tech holdings, Teladoc Health, Roku, and Roblox, is down 20% to 40% year to date as investors worry about rising interest and inflation rates.

However, a significant chunk of the interview was devoted to a personal assault on Cathie Wood, who was named the most excellent stock picker in 2020 by Bloomberg's then-Editor-in-Chief Matthew Winkler after correctly forecasting that Tesla will one day be valued at more than $1 trillion.

Wood bluntly ignored Tuttle Capital Management's Short Innovation ETF (SARK), which tracks the inverse performance of ARKK using swaps contracts for the sole purpose of betting against Cathie Wood's selections. "They're not conducting any research." She explained, "All they're doing is shorting innovation."

Of course, SARK is betting against Cathie Woods, not on innovation. "Well, we stand for invention," Wood responded. The SARK ETF has gained 55 percent since its debut, whereas the ARKK ETF has declined by 42 percent.

Tuttle Capital Management CEO Matthew Tuttle chimed in on the SARK ETF, calling it a "tool" for investors. According to SARK, "to convey a negative view of the market, innovative enterprises, the current rising rate environment, or a [specific] portfolio manager if they wish." "It's un-American not to have options in the marketplace," Tuttle told Insider on Thursday.

In any event, Wood is making progress. Her main concern currently is bearish calls on her ETF. "Our major concern is that our investors convert temporary losses into long-term losses," Wood continued.